The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-...(and during 9 scheduled visits over 12 mo...),Health
Navigation Links
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Date:9/5/2007
and during 9 scheduled visits over 12 months. Regular ECG's were also transmitted when patients were asymptomatic. The primary end point was time from randomization to first documented AF/AFL recurrence.
About Dronedarone (MULTAQ(TM))
Dronedarone is a novel multi-channel blocker, anti-arrhythmic drug (AAD) under development, discovered and developed by sanofi-aventis for the treatment of atrial fibrillation and atrial flutter.
About sanofi-aventis
Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Forward Looking Statements
This press release contains forward-looking statements as defined in
the Private Securities Litigation Reform Act of 1995, as amended.
Forward-looking statements are statements that are not historical facts.
These statements include financial projections and estimates and their
underlying assumptions, statements regarding plans, objectives, intentions
and expectations with respect to future events, operations, products and
services, and statements regarding future performance. Forward-looking
statements are generally identified by the words "expects," "anticipates,"
"believes," "intends," "estimates," "plans" and similar expressions.
Although sanofi-aventis' management believes that the expectations
reflected in such forward-looking statements are reasonable, investors are
cautioned that forward-looking information and statements are subject to
various risks and uncertainties, many of which are difficult to predict and
generally beyond the control of sanofi-aventis, that could cause actual
results and developments to differ materially from those e
'/>"/>
| SOURCE sanofi-aventis Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Arsenic May Have Been Responsible For The Madness Of King George III Of England
2. Indian Surgeon Conducts 70 Surgeries During His Holidays In England
3. Illegal Drug Use In England Mounting Up At An Alarming Rate
4. What Will Primary Care Look Like In England by 2015?
5. Ayurvedic Massage & English Food May Cheer England Team
6. Suicide Rates Drop To Lowest Ever In England
7. Head Of The Church Of England Asks NHS To Respect Patient Needs
8. More Accidents on England’s Road - Statistics Revea
9. England in the Grip of Dangerous Alcohol Addiction
10. Increase of Cancer drug usage in England
11. Cancer Drug Banned in England
Post Your Comments:
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3[0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana[0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use[0] The Leapfrog Group Releases Its 2009 Top Hospitals List[0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers[0] Potential new 'twist' in breast cancer detection
...new genetic risk factors for rheumatoid arthritis ... risk factors identified so far have been associat...out two-thirds of RA patients, but distinguishing ... of Leiden University Medical Center in The Nether...
...search for Usability Evaluation of HIT Providers ,...eed for understanding the usability of Electronic ...tric.com ) launches the first syndicated user per...n now is usability. Up to now the focus for compar...
...k, but human application is unclear , , TU... put down that protein shake -- at least if you,re...n protein spell trouble for rats that already eat ... about protein in the development of diabetes, sai...
...pectation may be factors in helping older adults r...n, say researchers with the Birmingham Veterans Ad... Alabama at Birmingham). In findings published in ... and more completely than did patients hospitalize...
... Cross Blue Shield of Georgia (BCBSGa) announced t...t rate for clinical psychologists by approximately...your auto mechanic or home handyman per hour. , ...al psychologists were reimbursed by BCBSGa nearl...
... Vision Screenings , , SAN ANTONIO, April 7 Sa...Vision eye care professionals are teaming up with ...ter to provide free vision screenings for children...tion and a free pair of eyeglasses from participat...
Other Medicine News:Health News:Genetic risk factors play role in autoantibody-negative rheumatoid arthritis 2Health News:EMRs Put to the Test on Usability 2Health News:EMRs Put to the Test on Usability 3Health News:Protein Might Be a Troublesome Nutrient 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 3Health News:Blue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological Association 2Health News:Blue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological Association 3Health News:Local EyeMasters Stores and Davis Vision to Team Up with San Antonio Spurs 2Genetic risk factors play role in autoantibody-negative rheumatoid arthritisEMRs Put to the Test on UsabilityProtein Might Be a Troublesome NutrientVA/UAB study looks at functional decline in older patients after hospitalizationBlue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological AssociationLocal EyeMasters Stores and Davis Vision to Team Up with San Antonio Spurs
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday October 29 2009 5302 1AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday October 29 2009 5302 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 1CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 3Liver Cancer Patients May Get Hope 59093 1Liver Cancer Patients May Get Hope 59093 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue
Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
Other Medicine Technology:DermaGen AB Receives Over 1 Million Euros From a New Share Issue 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue 3Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 2Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 3Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 4Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 5English & Spanish Medical Words & Phrases, 3rd Ed.
PocketBilling©
BluefishRx ICD-9 2005 Coding Tool
MD Coder Pocket PC 2006
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |